This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsClick Chemistry and Applications · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds
Following the publication of this article [1], concerns were raised that the NMR spectroscopy data pertaining to the characterization of Ph-triazole are not provided with [1], and that the Synthesis of the Ph-triazole subsection of the Materials and methods section provides insufficient detail regarding the “various spectroscopic techniques” used to purify and characterize Ph-triazole.
Upon editorial reassessment of [1], similarities were noted between multiple regions within multiple panels in Fig 9, and it was noted that the individual-level data underlying the graphs presented in Figs 1, 3-4, 7-10, and S1-S3 were not provided with [1].
The corresponding author’s response did not resolve the journal’s concerns.
In light of the above concerns, which call into question the integrity and reliability of the published results, the PLOS One Editors retract this article.
LZ responded but expressed neither agreement nor disagreement with the editorial decision. NZ, XL, FL, JJ, and TZ either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.